A SYSTEMATIC REVIEW AND POOLED DATA ANALYSIS OF SAFETY PARAMETERS IN PHASE 1 CLINICAL TRIALS AT THE JANSSEN R&D CLINICAL PHARMACOLOGY UNIT.

Mannaert E.; Rasschaert F.; Hosman T.; Van Looy T.; Lenders S.; Coenen E.

首页> 外文期刊>Clinical Pharmacology and Therapeutics >A SYSTEMATIC REVIEW AND POOLED DATA ANALYSIS OF SAFETY PARAMETERS IN PHASE 1 CLINICAL TRIALS AT THE JANSSEN R&D CLINICAL PHARMACOLOGY UNIT.

【24h】

A SYSTEMATIC REVIEW AND POOLED DATA ANALYSIS OF SAFETY PARAMETERS IN PHASE 1 CLINICAL TRIALS AT THE JANSSEN R&D CLINICAL PHARMACOLOGY UNIT.

机译：Janssen R＆D临床药理学单元的1阶段临床试验安全参数的系统评价与汇总数据分析。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical Pharmacology and Therapeutics》 |2020年第s1期|共1页
作者
Mannaert E.; Rasschaert F.; Hosman T.; Van Looy T.; Lenders S.; Coenen E.;
展开▼
作者单位

Janssen Res &

Dev Raritan NJ USA;

Janssen Res &

Dev Raritan NJ USA;

Janssen Res &

Dev Raritan NJ USA;

Janssen Res &

Dev Raritan NJ USA;

Janssen Res &

Dev Raritan NJ USA;

Janssen Res &

Dev Raritan NJ USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. A SYSTEMATIC REVIEW AND POOLED DATA ANALYSIS OF SAFETY PARAMETERS IN PHASE 1 CLINICAL TRIALS AT THE JANSSEN R&D CLINICAL PHARMACOLOGY UNIT. [J] . Mannaert E., Rasschaert F., Hosman T., Clinical Pharmacology and Therapeutics . 2020,第S1期

机译：Janssen R＆D临床药理学单元的1阶段临床试验安全参数的系统评价与汇总数据分析。
2. Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open-label extension trial of the interleukin-12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis [J] . LangleyR.G., PappK., GottliebA.B., Journal of the European Academy of Dermatology and Venereology: JEADV . 2013,第10期

机译：安全性来自对中度至重度牛皮癣的随机对照II期和III期临床试验的汇总分析以及白介素12/23单克隆抗体briakinumab的开放标签扩展试验的中期数据
3. Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials [J] . Kelly Karen, Infante Jeffrey R., Taylor Matthew H., Cancer: A Journal of the American Cancer Society . 2018,第9期

机译：高级实体肿瘤患者Avelumab的安全谱：来自第1阶段标枪实体肿瘤和第2阶段Javelin Merkel 200临床试验的汇总分析
4. ADVERSE EVENT REPORTING IN COMPANION ANIMAL CLINICAL TRIALS EVALUATING CANCER THERAPY: A SYSTEMATIC REVIEW [C] . Michelle Giuffrida Conference of the American^College^of^Veterinary^Internal^Medicine . 2016

机译：伴侣动物临床试验评估癌症治疗的不良事件报告：系统审查
5. Neurofeedback as a Treatment for ADHD: A Systematic Review of Current Evidence and Clinical Trials [D] . Hagan, Elizabeth Ann Stevenson. 2019

机译：神经反馈治疗多动症：当前证据和临床试验的系统评价
6. A Systematic Review and Pooled Analysis of Select Safety Parameters Among Normal Healthy Volunteers Taking Placebo in Phase 1 Clinical Trials [O] . Tina C. Young, Subasree Srinivasan, Marion L. Vetter, -1

机译：在第一阶段临床试验中接受安慰剂的正常健康志愿者中系统选择安全性参数的系统回顾和汇总分析
7. Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials. [O] . Jabbour, Serge, Seufert, Jochen, Scheen, André, 2017

机译：Dapagliflozin在2型糖尿病患者中的应用：来自IIb / III期临床试验的安全性数据汇总分析。

A SYSTEMATIC REVIEW AND POOLED DATA ANALYSIS OF SAFETY PARAMETERS IN PHASE 1 CLINICAL TRIALS AT THE JANSSEN R&D CLINICAL PHARMACOLOGY UNIT.

著录项

相似文献

相关主题

期刊订阅